Collegium Pharmaceutical (COLL) Operating Expenses (2014 - 2026)

Collegium Pharmaceutical's Operating Expenses history runs 13 years deep, the most recent figure standing at $86.4 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 14.16% year-over-year to $86.4 million; the TTM figure through Mar 2026 stood at $294.3 million (up 22.08% YoY), while the FY2025 annual figure was $283.6 million, up 36.72% from the prior year.
• Operating Expenses was $86.4 million for Q1 2026 at Collegium Pharmaceutical, up from $67.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $86.4 million in Q1 2026 to a low of $32.9 million in Q4 2023.
• Historically, Operating Expenses has averaged $53.7 million across 5 years, with a median of $52.8 million in 2023.
• Biggest YoY gain for Operating Expenses was 82.68% in 2024; the steepest drop was 20.45% in 2024.
• A 5-year view of Operating Expenses shows it stood at $38.0 million in 2022, then dropped by 13.38% to $32.9 million in 2023, then surged by 82.68% to $60.2 million in 2024, then advanced by 12.37% to $67.6 million in 2025, then grew by 27.7% to $86.4 million in 2026.
• The last three Operating Expenses figures came in at $86.4 million (Q1 2026), $67.6 million (Q4 2025), and $67.1 million (Q3 2025), per Business Quant data.